Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
about
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineResistance and escape from antiangiogenesis therapy: clinical implications and future strategiesSOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death.Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data.Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta-analysis.Not too big, not too small: a goldilocks approach to sample size selection.A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer.
P2860
Q26853619-95B75116-A485-490C-BEB2-646344983D8AQ27016629-A30970E8-27D0-4419-9C16-92497F305706Q37148642-87F85135-7C41-44CF-BB56-4D3EDFE6A6CBQ37489864-084E2F45-3E90-46CA-9C06-64A64DF9CC24Q37650708-FEBA06DB-1463-47BC-BB57-40926ABA5537Q38205153-9A6B967A-36AD-4044-B505-0ED255A21991Q38380059-07A7EBFF-1761-4A60-9040-4451F280314AQ38652510-D6AD2F6D-D2B3-4BB5-9BDA-589F6ED5D425Q38682028-08EE9FAA-6C76-40DD-8953-C706178D41C6Q44471801-AF1D3B7C-601E-4A66-AD41-8987792B18CBQ47117841-863A3A51-6628-46E4-857E-97F09FEF8207
P2860
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Phase III trial evaluating wee ...... ine in operable breast cancer.
@en
Phase III trial evaluating wee ...... ine in operable breast cancer.
@nl
type
label
Phase III trial evaluating wee ...... ine in operable breast cancer.
@en
Phase III trial evaluating wee ...... ine in operable breast cancer.
@nl
prefLabel
Phase III trial evaluating wee ...... ine in operable breast cancer.
@en
Phase III trial evaluating wee ...... ine in operable breast cancer.
@nl
P2093
P356
P1476
Phase III trial evaluating wee ...... ine in operable breast cancer.
@en
P2093
Abenaa M Brewster
Aman U Buzdar
Ana M Gonzalez-Angulo
Catherine M Kelly
Daniel J Booser
Eva S Thomas
Gabriel N Hortobagyi
Kelly K Hunt
Kristine Broglio
Marjorie C Green
P304
P356
10.1200/JCO.2011.36.2079
P407
P577
2012-02-13T00:00:00Z